Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera

Parasites and Vectors

Volumn 1, Issue 1, 2008, Pages

  De Moraes, Milene H ^a   Guarneri, Alessandra A ^a,b   Girardi, Fabiana P ^a   Rodrigues, Juliana B ^a   Eger, Iriane ^a,c   Tyler, Kevin M ^d   Steindel, Mário ^a   Grisard, Edmundo C ^a,d  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; EPIMASTIGOTE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; SEROLOGY; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WESTERN BLOTTING;

TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI;

EID: 64949191444     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-1-20     Document Type: Article

References (44)

1. Trypanosoma rangeli. A D' Alessandro NG Saravia, Protozoal Disease Oxford: University Press, Gilles HM, 1999 398 412
2. Characterization of Trypanosoma rangeli strains isolated in central and south America: on overview. EC Grisard M Steindel AA Guarneri I Eger-Mangrich DA Campbell AJ Romanha, Mem Inst Oswaldo Cruz 1999 94 203 209 10.1590/S0074- 02761999000200015 10224529
3. Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review. F Guhl GA Vallejo, Mem Inst Oswaldo Cruz 2003 98 435 442 10.1590/S0074- 02762003000400001 12937750
4. An update on Chagas disease (human American trypanosomiasis). A Moncayo MI Ortiz Yanine, Ann Trop Med Parasitol 2006 100 663 677 10.1179/ 136485906X112248 17227647
5. Antigenic make up of Trypanosoma cruzi culture forms: Identification of a specific component. D Afchain D Le Ray J Fruit A Capron, J Parasitol 1979 65 314 507 10.2307/3280312 376821
6. Antibodies against Trypanosoma cruzi in mice infected with T. rangeli. F Guhl CJ Marinkelle, Ann Trop Med Parasitol 1982 76 361 6812517
7. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli. JA O'Daly H Carrasco V Fernandez MB Rodriguez, Acta Trop 1994 56 265 287 10.1016/0001-706X(94)90099-X 8023751
8. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. C Zũiga T Palau P Penin C Gamallo JA de Diego, Trop Med Int Health 1997 2 482 427 10.1046/j.1365-3156.1997.d01- 297.x 9217704
9. Antibody response to experimental Trypanosoma rangeli infection and its implications for immunodiagnosis of South American trypanosomiasis. F Guhl L Hudson CJ Marinkelle SJ Morgan C Jaramillo, Acta Trop 1985 42 312 318
10. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice. A Saldãa OE Sousa A rn, Scand J Immunol 1995 42 644 650 10.1111/j.1365-3083.1995.tb03707.x 8552988
11. Trypanosoma rangeli and Trypanosoma cruzi: cross-reaction among their immunogenic components. A Saldãa OE Sousa, Mem Inst Oswaldo Cruz 1996 91 81 82 8734953
12. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. A Saldãa OE Sousa, J Parasitol 1996 82 363 366 10.2307/3284185 8604121
13. Serological diagnosis of Trypanosoma rangeli infected patients. A comparison of different methods and its implications for the diagnosis of Chagas' disease. JE Vasquez J Krusnell A Orn OE Sousa RA Harris, Scand J Immunol 1997 45 322 330 10.1046/j.1365-3083.1997.d01-405.x 9122624
14. Clinical Trypanosoma rangeli infection as a complication of Chagas' disease. F Guhl L Hudson CJ Marinkelle CA Jaramillo D Bridge, Parasitology 1987 94 475 484 2441341
15. Evaluation of serological tests to identify human Trypanosoma cruzi infection and cross-reactivity with Trypanosoma rangeli and Leishmania spp. cases. ZC Caballero OE Sousa WP Marques A Saez-Alquezar ES Umezawa, Clin Vaccine Immunol 2007 14 1045 1049 17522327 10.1128/CVI.00127-07
16. Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. AO Luquetti C Ponce E Ponce J Esfandiari A Schijman S Revollo N Ãez B Zingales R Ramgel-Aldao A Gonzalez MJ Levin ES Umezawa J Franco da Silveira, Diagn Microbiol Infect Dis 2003 46 265 271 10.1016/S0732-8893(03)00051-8 12944018
17. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. EP Silveira-Lacerda AG Silva SF Junior MA Souza N Kesper A Botelho-Filho ES Umezawa, Vox Sang 2004 87 204 207 10.1111/j.1423-0410.2004. 00571.x 15569074
18. Consenso Brasileiro sobre a Doença de Chagas. SVS/MS Secretaria de Vigilncia em Sade do Ministério da Sade, Rev Soc Bras Med Trop 2005 38 Suppl III 1 29
19. Trypanosomatid isolates from Honduras: Differentiation between Trypanosoma cruzi and Trypanosoma rangeli. L Acosta AJ Romanha H Cosenza AU Krettli, Am J Trop Med Hyg 1991 44 676 683 1907109
20. Detection of Chagas infections using Trypanosoma evansi crude antigen demonstrates high cross-reactions with Trypanosoma cruzi. M Desquesnes MF Bosseno SF Breniere, Infect Genet Evol 2007 7 457 462 10.1016/j.meegid.2007.01. 007 17337255
21. Total and specific anti-Trypanosoma cruzi immunoglobulin E in pericardial fluid samples from patients with chronic Chagas' disease. JR Mineo A Rocha JM Costa-Cruz AM da Silva DA Silva MD Goncalves-Pires ER Lopes E Chapadeiro, Trans R Soc Trop Med Hyg 1996 90 578 581 10.1016/S0035-9203(96)90331-4 8944279
22. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. J Morgan JC Dias ED Gontijo L Bahia-Oliveira R Correa-Oliveira DG Colley MR Powell, Am J Trop Med Hyg 1996 55 355 359 8916788
23. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease. J Morgan DG Colley JC Pinto Dias ED Gontijo L Bahia-Oliveira R Correa-Oliveira MR Powell, J Parasitol 1998 84 641 643 10.2307/3284744 9645878
24. Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia. N Medrano-Mercado MR Luz F Torrico G Tapia F Van Leuven TC Araujo-Jorge, Am J Trop Med Hyg 1996 54 154 161 8619440
25. Evaluation of 4 immunobiochemical/molecular methods for the identification of Trypanosoma cruzi and Trypanosoma rangeli strains. A Saldãa A Orn J Henriksson OE Sousa, Rev Med Panama 1993 18 41 52 8475337
26. Trypanosoma rangeli: identification and purification of a 48-kDa-specific antigen. A Saldãa RA Harris A Orn OE Sousa, J Parasitol 1998 84 67 73 10.2307/3284532 9488340
27. Immunobiochemical significance of Trypanosoma rangeli in the study of Trypanosoma cruzi. A Saldãa, From the Microbiology and Tumorbiology Center (MTC) Karolinska Institute, Stockoholm, Sweden and the Center for Research and Diagnosis of Parasitic Diseases (CIDEP), Faculty of Medicine, University of Panama 1997 7 51
28. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. A Moncayo, Mem Inst Oswaldo Cruz 2003 98 577 591 10.1590/S0074-02762003000500001 12973523
29. Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and assessment of antigen stability for the three assays. M Berrizbietia M Ndao M Gottschalk A Ache F Vasquez S Lacouture M Medina BJ Ward, J Clin Microbiol 2004 42 1766 1769 15071044 10.1128/JCM.42.4. 1766-1769.2004
30. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease. ES Umezawa MA Shikanai-Yasuda AM Stolf, J Clin Lab Anal 1996 10 407 413 10.1002/(SICI)1098-2825(1996)10:6<407::AID-JCLA16>3.0.CO;2-0 8951611
31. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. ES Umezawa SF Bastos JR Coura MJ Levin A Gonzalez R Rangel-Aldao B Zingales AO Luquetti JF da Silveira, Transfusion 2003 43 91 97 10.1046/j.1537-2995.2003.00279.x 12519436
32. Serodiagnosis of chronic Chagas infection by using EIE-Recombinant- Chagas-Biomanguinhos kit. YM Gomes VR Pereira M Nakazawa DS Rosa MD Barros AG Ferreira ED Silva SF Ogatta MA Krieger S Goldenberg, Mem Inst Oswaldo Cruz 2001 96 497 501 11391421
33. The clinical immunology of human Chagas disease. WO Dutra MO Rocha MM Teixeira, Trends Parasitol 2005 21 581 587 10.1016/j.pt.2005.09.007 16236550
34. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection. C Covarrubias M Cortez D Ferreira N Yoshida, Int J Parasitol 2007 37 1609 1616 10.1016/j.ijpara.2007.05.013 17640647
35. Serological diagnosis An Appraisal of Chagas disease serodiagnosis. ME Camargo, Chagas disease (American Trypanosomiasis), its impact on transfusion and clinical medicine São Paulo: Sociedade Brasileira de Hematologia e Hemoterapia, Wendel S, Brener Z, Camargo ME, Rassi A, 1992 165 178
36. Field evaluation of four novel enzyme immunoassays for Chagas' disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains. M Berrizbeitia M Ndao J Bubis M Gottschalk A Ache S Lacouture M Medina BJ Ward, Transfus Med 2006 16 419 431 10.1111/j.1365-3148. 2006.00703.x 17163873
37. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. B Basso L Cervetta E Moretti Y Carlier C Truyens, Vaccine 2004 22 1868 1872 10.1016/j.vaccine.2003.11.013 15121297
38. Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi. B Basso I Castro V Introini P Gil C Truyens E Moretti, Vaccine 2007 25 3855 3858 10.1016/j.vaccine.2007.01.114 17349724
39. Experimental Chagas disease. I. Study of different immunization conditions in the infection course. MV Introini B Basso ER Moretti, Bol Chil Parasitol 1998 53 45 51 10413878
40. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli immunized mice. B Basso ERA Moretti E Vottero-Cima, Am J Trop Med Hyg 1991 44 413 419 1828328
41. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. N Garg RL Tarleton, Infect Immun 2002 70 5547 5555 12228281 10.1128/IAI.70.10.5547-5555. 2002
42. Characterization of Trypanosoma cruzi isolated from humans, vectors and animal reservoirs following an outbreak of acute human Chagas disease in Brazil. M Steindel LK Pacheco D Scholl M Soares MH Moraes I Eger C Kosmann TCM Sincero PH Stoco SMF Murta CJ Carvalho-Pinto EC Grisard, Diag Microbiol Infect Dis 2008 60 25 32
43. Differentiation of Trypanosoma rangeli: high production of infective trypomastigote forms in vitro. L Koerich P Emmanuelle-Machado K Santos EC Grisard M Steindel, Parasitology 2002 88 21 25
44. Improved method for separation on CM-cellulose of the trypomastigote form of Trypanosoma cruzi from forms grown in fibroblast cell cultures. H Kanbara T Nakabayashi, Biken J 1983 26 63 65 6354174